, Réseau Epidémiologie et Information en Néphrologie (REIN) -Rapport annuel 2015
Les infections graves chez les patients en dialyse péritonéale et en hémodialyse chronique conventionnelle : péritonites et infections de la voie d'abord vasculaire, Réanimation, vol.17, issue.3, pp.233-241, 2008. ,
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population, Kidney Int, vol.58, pp.1758-64, 2000. ,
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration, J Infect Dis, vol.155, issue.1, pp.93-102, 1987. ,
Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria, Antimicrob Agents Chemother, vol.43, issue.3, pp.623-632, 1999. ,
Comparative study with enoxacin and ,
, , vol.31, pp.1054-60, 1987.
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance, Chest, vol.115, pp.19-23, 1999. ,
Bon usage des aminosides administrés par voie injectable gentamicine, tobramycine, nétilmicine, amikacine -Mise au point, 2011. ,
, Drug Prescribing in Renal Failure 5
American College of Physicians, 2007. ,
Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality, Antimicrob Agents Chemother, vol.41, issue.12, pp.2597-601, 1997. ,
Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing, Clin J Am Soc Nephrol, vol.3, issue.2, pp.355-61, 2008. ,
Development of a semimechanistic model to describe the pharmacokinetics of gentamicin in patients receiving hemodialysis, J Clin Pharmacol, 2006. ,
Dosing of gentamicin in patients with endstage renal disease receiving hemodialysis, J Clin Pharmacol, vol.46, issue.11, pp.1259-67, 2006. ,
Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate ?, Semin Dial, vol.22, issue.3, pp.225-255, 2009. ,
Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semimechanistic pharmacokinetic/pharmacodynamic model, J Antimicrob Chemother, 2016. ,
, MIC and zone diameter distributions and ECOFFs
Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered, Antimicrob Agents Chemother, vol.57, issue.2, pp.977-82, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00944357
Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units, Anaesth Crit Care Pain Med, 2016. ,
,
, mg/kg total body weight regimen, vol.40, pp.998-1005, 2014.
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock, Crit Care, 2010. ,
Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity, Int J Antimicrob Agents, vol.38, issue.2, pp.146-51, 2011. ,
,
, Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentration, Int J Antimicrob Agents, vol.46, issue.1, pp.21-28, 2015.
Administration des antibiotiques en réanimation, Congrès d'actualisation SFAR 2017 ,
,
, Réseau Epidémiologie et Information en Néphrologie -Rapport annuel 2015
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population, Kidney Int, vol.58, pp.1758-64, 2000. ,
Les infections graves chez les patients en dialyse péritonéale et en hémodialyse chronique conventionnelle : péritonites et infections de la voie d'abord vasculaire, Réanimation, vol.17, issue.3, pp.233-241, 2008. ,
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions, Lancet Infect Dis, vol.14, issue.6, pp.498-509, 2014. ,
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration, J Infect Dis, vol.155, issue.1, pp.93-102, 1987. ,
Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria, Antimicrob Agents Chemother, vol.43, issue.3, pp.623-632, 1999. ,
Comparative study with enoxacin and ,
, , vol.31, pp.1054-60, 1987.
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance, Chest, vol.115, pp.19-23, 1999. ,
Bon usage des aminosides administrés par voie injectable gentamicine, tobramycine, nétilmicine, amikacine -Mise au point, 2011. ,
, Drug Prescribing in Renal Failure 5
American College of Physicians, 2007. ,
Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality, Antimicrob Agents Chemother, vol.41, issue.12, pp.2597-601, 1997. ,
Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing, Clin J Am Soc Nephrol, vol.3, issue.2, pp.355-61, 2008. ,
Development of a semimechanistic model to describe the pharmacokinetics of gentamicin in patients receiving hemodialysis, J Clin Pharmacol, 2006. ,
Dosing of gentamicin in patients with endstage renal disease receiving hemodialysis, J Clin Pharmacol, vol.46, issue.11, pp.1259-67, 2006. ,
Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate ?, Semin Dial, vol.22, issue.3, pp.225-255, 2009. ,
Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semimechanistic pharmacokinetic/pharmacodynamic model, J Antimicrob Chemother, 2016. ,
Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services, J Clin Pharm Ther, vol.12, issue.5, pp.273-91, 1987. ,
The pharmacodynamics of aminoglycosides, Clin Infect Dis, vol.27, issue.1, pp.23-30, 1998. ,
Optimizing use of aminoglycosides in the critically ill. Semin Respir Crit Care Med, vol.28, pp.596-603, 2007. ,
The need for aminoglycosides in combination with ?-lactams for high-risk, febrile neutropaenic patients with leukaemia, Eur J Cancer, vol.43, issue.5, pp.13-22, 2007. ,
Betalactam monotherapy versus ß-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systématic review and meta-analysis of randomised trials, BMJ, vol.328, pp.668-672, 2004. ,
Betalactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis, Cochrane Database Syst Rev, vol.25, issue.1, p.3344, 2006. ,
Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to Gram-negative microorganisms, Antimicrob Agents Chemother, vol.54, issue.9, pp.3590-3596, 2010. ,
Guidelines on the prevention, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis and treatment of infective endocarditis of the European Society of Cardiology (ESC), Eur Heart J, vol.30, pp.2369-2413, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00465409
Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity, Antimicrob Agents Chemother, vol.34, issue.4, pp.614-635, 1990. ,
The postantibiotic effect: a review of in vitro and in vivo data, DICP, vol.25, issue.2, pp.153-63, 1991. ,
Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans. nfection, pp.459-64, 1996. ,
Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model, Antimicrob Agents Chemother, vol.35, issue.7, pp.1413-1435, 1991. ,
First-exposure adaptative résistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use, Antimicrob Agents Chemother, vol.35, pp.117-123, 1991. ,
Amonoglycosides-resistance mechanismsin multidrug-resistant Staphylococcus aureus clinical isolates, Curr Microbiol, vol.56, pp.558-562, 2008. ,
Therapeutic drug monitoring of amikacin in septic patients, Crit. Care Lond. Engl, vol.17, p.165, 2013. ,
Pharmacokinetic dosing of aminoglycosides : a controlled trial, Am J ,
, , vol.114, pp.194-198, 2003.
Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA), Scand J Infect Dis, vol.45, issue.3, pp.161-75, 2013. ,
Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock, Antimicrob Agents Chemother, vol.58, issue.12, pp.7468-74, 2014. ,
The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients, Surg Infect (Larchmt), vol.10, issue.6, pp.563-70, 2009. ,
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model, Antimicrob Agents Chemother, 1993. ,
Principes de l'adaptation posologique des antibiotiques lors d'une épuration extrarénale en réanimation, Réanimation juin, vol.19, issue.4, pp.339-346, 2010. ,
Antibiotic pharmacokinetic and pharmacodynamic considerations in patients with kidney disease, vol.17, pp.392-403, 2010. ,
,
, Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy, Arch Intern Med, vol.138, issue.11, pp.1621-1625, 1978.
,
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by Nacetylcysteine. Kidney Int, vol.72, pp.359-63, 2007. ,
Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen, Clin J Am Soc Nephrol, vol.2, issue.4, pp.694-703, 2007. ,
Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered, Antimicrob Agents Chemother, vol.57, issue.2, pp.977-82, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00944357
Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units, Anaesth Crit Care Pain Med, vol.35, issue.5, p.331, 2016. ,
,
, mg/kg total body weight regimen, vol.40, pp.998-1005, 2014.
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock, Crit Care, vol.14, issue.2, p.53, 2010. ,
Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity, Int J Antimicrob Agents, vol.38, issue.2, pp.146-51, 2011. ,
Administration des antibiotiques en réanimation, Congrés d'actualisation SFAR 2017 ,
,
, Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentration, Int J Antimicrob Agents, vol.46, issue.1, pp.21-28, 2015.